Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Lymphoma

3,4-methylenedioxyamphetamine has been researched along with Lymphoma in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.

Research Excerpts

ExcerptRelevanceReference
"To assess whether childhood cancer survivors experience difficulties in their romantic relationships during emerging adulthood (18-25 years) and to identify who may be at risk for long-term social sequelae."1.35Romantic relationships of emerging adult survivors of childhood cancer. ( Marshal, MP; Marsland, AL; Tersak, JM; Thompson, AL, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thompson, AL1
Marsland, AL1
Marshal, MP1
Tersak, JM1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Lymphoma

ArticleYear
Romantic relationships of emerging adult survivors of childhood cancer.
    Psycho-oncology, 2009, Volume: 18, Issue:7

    Topics: Adaptation, Psychological; Adolescent; Adult; Age Factors; Anxiety; Child; Child, Preschool; Female;

2009